https://www.selleckchem.com/pr....oducts/auranofin.htm
ns. The primary outcomes of this study include the feasibility of conducting an RCT using the Trial My App platform by reporting recruitment, retention, and completion statistics. We will validate app-entered data with a standard 7-day home blood pressure measurement method. Lastly, the pilot, nonblinded RCT will assess the effectiveness of the mHealth app in improving the control of hypertension compared with the control of hypertension in the educational control group. This study will determine if it is feasible to use the Trial My
Gefällt mir
Kommentar
Teilen
